CymitQuimica logo
Angiogenesi

Angiogenesi

Gli inibitori dell'angiogenesi sono composti che interferiscono con la formazione di nuovi vasi sanguigni, un processo cruciale nella crescita e metastasi del cancro. Inibendo l'angiogenesi, questi composti possono limitare l'apporto di sangue ai tumori, rallentandone o arrestando la crescita. Gli inibitori dell'angiogenesi sono fondamentali nella ricerca sul cancro e nello sviluppo terapeutico, offrendo approfondimenti sui meccanismi di progressione tumorale e potenziali trattamenti per il cancro e altre malattie legate all'angiogenesi. Presso CymitQuimica, offriamo un'ampia gamma di inibitori dell'angiogenesi di alta qualità per supportare le tue ricerche in oncologia e biologia vascolare.

Sottocategorie di "Angiogenesi"

Mostrare 6 più sottocategorie

Trovati 2121 prodotti di "Angiogenesi"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • PROTAC FAK degrader 1

    CAS:
    <p>PROTAC FAK degrader 1 is a selective and potent degrader of focal adhesion kinase (Fak) (IC50 of 6.5 nM).</p>
    Formula:C47H56F3N9O8S2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:996.13
  • PLM-101


    <p>PLM-101 is an anticancer compound orally active against acute myeloid leukemia by targeting FLT3 and RET.</p>
    Formula:C22H22FN5O2
    Colore e forma:Solid
    Peso molecolare:407.44
  • EGFR-IN-116


    EGFR-IN-116 (compound 14D) is an antineoplastic agent. It exhibits an IC50 value of 0.103 μM for EGFR, 0.069 μM for VEGFR-2, and 19.74 μM for Topo II.
    Formula:C26H22N6O2S
    Peso molecolare:482.1525
  • AMT-562


    AMT-562 is an antibody-drug conjugate (ADC) composed of a novel anti-HER3 antibody, Ab562, linked to the linker Mc-VC-PAB and the topoisomerase I inhibitor, Exatecan. The ADC's toxic component and linker are represented as MC-VA-PAB-Exatecan. AMT-562 can induce apoptosis and exhibits antitumor activity against pancreatic, esophageal, and gastric cancers.
    Colore e forma:Odour Liquid
  • PACAP-38 (31-38), human, mouse, rat

    CAS:
    <p>PACAP-38 (31-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production</p>
    Formula:C47H83N17O11
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:1062.27
  • Arginyl-Glutamine

    CAS:
    Arginyl-Glutamine (Arg-Gln) is a dipeptide nutritional supplement that protects neonatal mice from hyperoxia-induced lung injury, lowering VEGF levels.
    Formula:C11H22N6O4
    Purezza:95.2%
    Colore e forma:Solid
    Peso molecolare:302.33
  • SJF 1521

    CAS:
    SJF 1521 is an EGFR degrader belonging to the PROTAC class that selectively degrades EGFR while preserving HER2.
    Formula:C57H61ClFN7O9S
    Purezza:99.20%
    Colore e forma:Solid
    Peso molecolare:1074.65
  • FDU73


    <p>FDU73 is a potent and selective BTK PROTAC degrader with a DC50 of 2.9 nM in JeKo-1 cells. It inhibits tumor cell proliferation and exhibits antitumor activity.</p>
    Colore e forma:Odour Solid
  • Simotinib hydrochloride

    CAS:
    Simotinib hydrochloride: selective oral EGFR inhibitor, IC50 19.9 nM, potent anticancer agent.
    Formula:C25H27Cl2FN4O4
    Colore e forma:Solid
    Peso molecolare:537.41
  • WDR5 ligand 2

    CAS:
    <p>WDR5ligand 2 is a ligand for WDR5 and can be utilized in the synthesis of PROTAC WDR5degrader 1.</p>
    Formula:C29H31F3N4O4
    Colore e forma:Solid
    Peso molecolare:556.576
  • EGFR/CDK2-IN-4


    EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK-2.
    Formula:C24H16N6OS2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:468.55
  • FGFR1 inhibitor-2

    CAS:
    FGFR1 inhibitor-2, potent at 4.55 μM IC50 in MDA-MB-231, targets triple-negative breast cancer.
    Formula:C25H22F5N3O3
    Colore e forma:Solid
    Peso molecolare:507.461
  • CS-VIP 8 TFA


    CS-VIP 8 TFA is a selective allosteric inhibitor of the WDR5 protein (Ki= 0.008 μM). It induces a conformational change in the MLL1 complex, leading to the dissociation of MLL1 from the complex, thereby inhibiting the MLL1 histone methyltransferase activity and modulating HOX gene expression. CS-VIP 8 TFA shows potential for research in hematological disorders such as leukemia.
    Formula:C45H53F7N12O9
    Colore e forma:Solid
    Peso molecolare:1038.39467
  • GBD-9

    CAS:
    GBD-9, a dual-mechanism degrader, effectively promotes the degradation of BTK and GSPT1 through recruitment of E3 ligase cereblon (CRBN).
    Formula:C44H47N9O6
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:797.9
  • JAK3-IN-14

    CAS:
    JAK3-IN-14 is a potent, selective and orally active FLT3 inhibitor, with IC50s of ∼40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively.
    Formula:C18H13N3O
    Purezza:98.29%
    Colore e forma:Soild
    Peso molecolare:287.32
  • DSPE-PEG1000-GE11


    <p>DSPE-PEG1000-GE11 is a PEG compound made up of DSPE and an EGFR-targeting peptide (GE11). GE11 is applicable for cancer cells overexpressing EGFR. DSPE-PEG1000-GE11 serves a role in drug delivery.</p>
    Colore e forma:Odour Solid
  • TYK2 activator-1


    TYK2activator-1 (16b) is a TYK2 activator with an EC50 value of 1.78 μM. It inhibits JAK2 and JAK3 with IC50 values of 6.8 μM and 6.3 μM, respectively.
    Formula:C23H21FN4O2
    Colore e forma:Solid
    Peso molecolare:404.16485
  • BCPyr

    CAS:
    BCPyr is a new candidate BTK degrader ( DC 50 = 800 nM).
    Formula:C58H65F2N11O8
    Colore e forma:Solid
    Peso molecolare:1082.224
  • ALK-IN-12

    CAS:
    ALK-IN-12: potent ALK inhibitor (IC50: 0.18 nM), affects IGF1R and InsR (IC50: 20.3/90.6 nM), potential for cancer therapy.
    Formula:C24H30ClN6O2P
    Colore e forma:Solid
    Peso molecolare:500.97
  • PROTAC FLT3/CDKs degrader-1


    <p>PROTACFLT3/CDKs degrader-1 (Compound C3) is an agent that degrades cyclin-dependent kinase (CDK2 with a DC50 of 18.73 nM) and FMS-like tyrosine kinase 3 (FLT3). It induces differentiation in HL-60 cells, achieving a 72.77% differentiation rate at 6.25 nM, and inhibits proliferation of acute myeloid leukemia (AML) cells, with an IC50 ranging from 2.9 to 37 nM. PROTACFLT3/CDKs degrader-1 demonstrates potential for improving the treatment of AML.</p>
    Formula:C40H42N12O5
    Peso molecolare:770.34011